NASDAQ · Financial Statements

Health Catalyst, Inc (HCAT) Financial Statements

$1.69 NASDAQ: HCAT Market Cap $127.18M

Health Catalyst, Inc most recently reported annual revenue of $311.0M, a net loss of $178.0M. Revenue grew at an average annual rate of 10.5% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Health Catalyst, Inc: Revenue rose from $73.0M in 2017 to $311.0M in 2025, a change of +326.0% over 8 years; net profit was positive in 0 of 9 reported years; operating margin moved from -62.3% to -11.6%, a shift of +50.7 percentage points; the most recent year shows a net loss of $178.0M.

Income Statement — 9 Years (USD millions)

Metric201720182019202020212022202320242025
Revenue$73.0M$113.0M$155.0M$189.0M$242.0M$276.0M$296.0M$307.0M$311.0M
Operating Expenses$119.0M$173.0M$210.0M$285.0M$386.0M$416.0M$423.0M$376.0M$347.0M
Operating Profit$-46.0M$-60.0M$-55.0M$-96.0M$-144.0M$-140.0M$-127.0M$-70.0M$-36.0M
Operating Margin-62.3%-53.4%-35.4%-50.9%-59.4%-50.7%-42.9%-22.8%-11.6%
Other Income$-1.0M$-2.0M$-5.0M$-20.0M$-16.0M$-2.0M$9.0M$1.0M$-141.0M
Interest$2.0M$3.0M$6.0M$14.0M$17.0M$7.0M$7.0M$17.0M$16.0M
Depreciation$6.0M$7.0M$9.0M$19.0M$41.0M$52.0M$42.0M$41.0M$51.0M
Profit Before Tax$-47.0M$-62.0M$-60.0M$-116.0M$-160.0M$-142.0M$-118.0M$-69.0M$-177.0M
Tax$-60,000$220,000$-240,000$1.0M$4.3M$3.0M$-300,000$-480,000$-400,000
Net Profit$-47.0M$-62.0M$-60.0M$-115.0M$-153.0M$-137.0M$-118.0M$-70.0M$-178.0M
EPS$-1.69$-2.23$-3.21$-2.91$-3.23$-2.54$-2.09$-1.15$-2.55
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$74.0M$75.0M$75.0M$76.0M$76.0M$80.0M$79.0M$81.0M$76.0M$75.0M$71.0M$70.0M
Operating Expenses$98.0M$108.0M$98.0M$92.0M$90.0M$97.0M$100.0M$118.0M$94.0M$71.0M$78.0M$107.0M
Operating Profit$-25.0M$-33.0M$-23.0M$-16.0M$-14.0M$-17.0M$-20.0M$-37.0M$-18.0M$3.0M$-7.0M$-36.0M
Operating Margin-33.3%-43.7%-30.5%-20.8%-17.9%-22.0%-25.4%-46.0%-22.9%4.4%-9.5%-51.8%
Interest$2.0M$2.0M$2.0M$2.0M$6.0M$7.0M$7.0M$6.0M$6.0M$6.0M$5.0M$5.0M
Profit Before Tax$-22.0M$-30.0M$-20.0M$-13.0M$-15.0M$-20.0M$-24.0M$-41.0M$-22.0M$-91.0M$-111.0M$-40.0M
Tax$-270,000$-470,000$-550,000$-520,000$3.1M$-3.1M$-910,000$-200,000$-180,000$-420,000$-370,000$-780,000
Net Profit$-22.0M$-30.0M$-21.0M$-14.0M$-15.0M$-21.0M$-24.0M$-41.0M$-22.0M$-91.0M$-111.0M$-41.0M
EPS$-0.39$-0.53$-0.35$-0.23$-0.24$-0.33$-0.35$-0.59$-0.32$-1.28$-1.53$-0.55

Over the 9 years reported for Health Catalyst, Inc, borrowings increased from $13.0M in 2017 to $171.0M in 2025, cash stood at $51.0M in the latest year, shareholders' equity was $1.6B, current assets covered current liabilities 1.88 times.

Balance Sheet — 9 Years (USD millions)

Metric201720182019202020212022202320242025
Total Assets$110.0M$111.0M$302.0M$578.0M$832.0M$752.0M$702.0M$859.0M$503.0M
Current Assets$71.0M$67.0M$264.0M$330.0M$508.0M$428.0M$393.0M$466.0M$169.0M
Cash$23.0M$28.0M$18.0M$92.0M$193.0M$116.0M$106.0M$250.0M$51.0M
Inventory$0$0$0$0$0$0$0$0$0
Receivables$17.0M$28.0M$28.0M$48.0M$49.0M$48.0M$60.0M$57.0M$59.0M
Fixed Assets$5.0M$11.0M$8.0M$38.0M$44.0M$43.0M$40.0M$41.0M$40.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0
Investments$28.0M$5.0M$210.0M$179.0M$252.0M$247.0M$211.0M$142.0M$45.0M
Other Assets$4.0M$4.0M$4.0M$108.0M$170.0M$186.0M$191.0M$260.0M$209.0M
Total Liabilities$370.0M$486.0M$102.0M$302.0M$310.0M$327.0M$335.0M$494.0M$257.0M
Current Liabilities$31.0M$42.0M$48.0M$88.0M$93.0M$83.0M$89.0M$326.0M$90.0M
Borrowings$13.0M$27.0M$53.0M$195.0M$205.0M$248.0M$249.0M$402.0M$171.0M
Other Liabilities$357.0M$459.0M$49.0M$106.0M$105.0M$79.0M$86.0M$91.0M$86.0M
Equity$0$0$0$0$0$1.4B$1.5B$1.6B$1.6B
Reserves$-259.0M$-375.0M$201.0M$276.0M$522.0M$425.0M$367.0M$365.0M$246.0M

For Health Catalyst, Inc, operating cash flow was positive in 2 of 9 reported years; free cash flow in the latest year was $0; free cash flow was positive in 0 of 9 years; financing activities used $5.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 9 Years (USD millions)

Metric201720182019202020212022202320242025
Operating Cash Flow$-37.0M$-40.0M$-32.0M$-26.0M$-23.0M$-35.0M$-33.0M$15.0M$1.0M
Investing Cash Flow$19.0M$19.0M$-214.0M$-93.0M$-158.0M$-56.0M$6.0M$-39.0M$35.0M
Financing Cash Flow$15.0M$14.0M$-1.0M$-23.0M$19.0M$-10.0M$3.0M$-2.0M$-5.0M
Net Cash Flow$10.0M$5.0M$-10.0M$74.0M$101.0M$-77.0M$-10.0M$143.0M$-199.0M
Free Cash Flow$-40.0M$-43.0M$-37.0M$-37.0M$-42.0M$-53.0M$-47.0M$-2.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-1.28
FCF Yield10.04%
Quick Ratio2.70
Interest Coverage-2.80
Return 1Y-40.67%
Return 3Y-81.38%
Return 5Y-95.82%

Health Catalyst, Inc (HCAT) financials — frequently asked questions

What is Health Catalyst, Inc's annual revenue?

Health Catalyst, Inc (HCAT) reported annual revenue of $311.0M in its most recent fiscal year.

What is Health Catalyst, Inc's net profit?

Health Catalyst, Inc (HCAT) reported a net loss of $178.0M in its most recent fiscal year.

What is HCAT EV/EBITDA?

Health Catalyst, Inc's enterprise value to EBITDA (EV/EBITDA) ratio is -1.28. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
HCAT Overview HCAT Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.